This meta-analysis of 3 randomized clinical trials evaluates the association of combined anti-PD-L1 agents with survival and response rate among patients with metastatic renal cell carcinoma.
Comparison of Anti–Programmed Cell Death Ligand 1 Therapy Combinations vs Sunitinib for Metastatic Renal Cell Carcinoma: A Meta-analysis / Maiorano, Brigida Anna; Ciardiello, Davide; Maiello, Evaristo; Roviello, Giandomenico. - In: JAMA NETWORK OPEN. - ISSN 2574-3805. - ELETTRONICO. - 6:(2023), pp. 1-3. [10.1001/jamanetworkopen.2023.14144]
Comparison of Anti–Programmed Cell Death Ligand 1 Therapy Combinations vs Sunitinib for Metastatic Renal Cell Carcinoma: A Meta-analysis
Roviello, Giandomenico
2023
Abstract
This meta-analysis of 3 randomized clinical trials evaluates the association of combined anti-PD-L1 agents with survival and response rate among patients with metastatic renal cell carcinoma.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Maiorano et al., Jama Netw Open, 2023.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
322.44 kB
Formato
Adobe PDF
|
322.44 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
